Načítá se...
Diabetes pathogenic mechanisms and potential new therapies based upon a novel target called TXNIP
PURPOSE OF REVIEW: Thioredoxin-interacting protein (TXNIP) has emerged as a major factor regulating pancreatic beta cell dysfunction and death, key processes in the pathogenesis of type 1 and type 2 diabetes. Accumulating evidence based on basic, pre-clinical and retrospective epidemiological resear...
Uloženo v:
| Vydáno v: | Curr Opin Endocrinol Diabetes Obes |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5831522/ https://ncbi.nlm.nih.gov/pubmed/29356688 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MED.0000000000000391 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|